A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Clinical trial NCT05675410 · RECRUITING
Trial details
- NCT number
- NCT05675410
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2031-04-28
- Enrollment
- 1875
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.